The China Mail - Warmer noses are better at fighting colds: study

USD -
AED 3.6725
AFN 64.000071
ALL 82.507456
AMD 367.703735
ANG 1.790403
AOA 917.486806
ARS 1481.204487
AUD 1.455583
AWG 1.8
AZN 1.702518
BAM 1.713097
BBD 2.011903
BDT 123.11735
BGN 1.69088
BHD 0.37663
BIF 2971.783429
BMD 1
BND 1.292103
BOB 6.917906
BRL 5.173975
BSD 0.998945
BTN 94.390722
BWP 13.575192
BYN 2.897008
BYR 19600
BZD 2.009013
CAD 1.42389
CDF 2274.999746
CHF 0.809855
CLF 0.023433
CLP 922.240245
CNY 6.79395
CNH 6.794015
COP 3444.75
CRC 453.094276
CUC 1
CUP 26.5
CVE 96.581777
CZK 21.29395
DJF 177.883078
DKK 6.56346
DOP 59.402385
DZD 133.344161
EGP 49.318599
ERN 15
ETB 161.045542
EUR 0.87812
FJD 2.24975
FKP 0.75464
GBP 0.75585
GEL 2.640095
GGP 0.75464
GHS 11.298312
GIP 0.75464
GMD 73.505896
GNF 8757.385047
GTQ 7.621225
GYD 208.956139
HKD 7.842625
HNL 26.733762
HRK 6.615302
HTG 130.560263
HUF 311.496947
IDR 17901.8
ILS 2.983605
IMP 0.75464
INR 94.644501
IQD 1308.597856
IRR 1376000.0002
ISK 126.459561
JEP 0.75464
JMD 157.289691
JOD 0.709016
JPY 162.355504
KES 129.450268
KGS 87.450264
KHR 4016.834619
KMF 431.999871
KPW 900.00035
KRW 1548.204971
KWD 0.30975
KYD 0.832454
KZT 485.019949
LAK 22404.211245
LBP 89452.529331
LKR 335.883613
LRD 181.802256
LSL 16.412646
LTL 2.95274
LVL 0.60489
LYD 6.417595
MAD 9.36107
MDL 17.65605
MGA 4250.809125
MKD 54.129403
MMK 2099.487458
MNT 3582.059186
MOP 8.069687
MRU 39.866691
MUR 47.189577
MVR 15.45991
MWK 1732.206908
MXN 17.492503
MYR 4.072201
MZN 63.849923
NAD 16.412646
NGN 1380.330343
NIO 36.762097
NOK 9.958035
NPR 151.021499
NZD 1.770775
OMR 0.384501
PAB 0.998971
PEN 3.411304
PGK 4.385719
PHP 61.271501
PKR 277.769934
PLN 3.766495
PYG 6083.007432
QAR 3.641301
RON 4.604802
RSD 103.084981
RUB 76.98988
RWF 1466.390474
SAR 3.752458
SBD 8.065041
SCR 13.42013
SDG 600.518606
SEK 9.737355
SGD 1.294798
SHP 0.746601
SLE 24.803463
SLL 20969.503664
SOS 570.895539
SRD 37.494501
STD 20697.981008
STN 21.459979
SVC 8.74059
SYP 110.532098
SZL 16.408648
THB 33.282006
TJS 9.260125
TMT 3.51
TND 2.958885
TOP 2.40776
TRY 46.658977
TTD 6.790721
TWD 31.854498
TZS 2628.473028
UAH 44.832941
UGX 3661.287144
UYU 40.195503
UZS 12039.275454
VES 622.24352
VND 26310
VUV 119.95305
WST 2.78094
XAF 574.561715
XAG 0.017427
XAU 0.000251
XCD 2.70255
XCG 1.800321
XDR 0.71457
XOF 574.541585
XPF 104.460551
YER 238.60124
ZAR 16.46094
ZMK 9001.203007
ZMW 18.085232
ZWL 321.999592
  • RBGPF

    0.6100

    65.61

    +0.93%

  • CMSC

    0.1300

    22.06

    +0.59%

  • GSK

    0.3100

    52.81

    +0.59%

  • JRI

    0.0700

    12.86

    +0.54%

  • CMSD

    0.1300

    21.9

    +0.59%

  • NGG

    0.7500

    83.76

    +0.9%

  • RIO

    0.5500

    94.29

    +0.58%

  • BCC

    -1.7600

    79.26

    -2.22%

  • RELX

    -0.0500

    31.29

    -0.16%

  • BCE

    -0.6600

    22.26

    -2.96%

  • RYCEF

    0.2900

    18.68

    +1.55%

  • BTI

    -0.0200

    62.74

    -0.03%

  • BP

    0.2200

    37.35

    +0.59%

  • AZN

    2.5400

    190.95

    +1.33%

  • VOD

    -0.2000

    13.69

    -1.46%

Warmer noses are better at fighting colds: study
Warmer noses are better at fighting colds: study / Photo: © AFP

Warmer noses are better at fighting colds: study

Chilly weather and common respiratory infections often go hand in hand.

Text size:

Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.

Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.

These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.

The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.

"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.

For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?

To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.

They found it did in fact produce EVs that target viruses.

In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.

These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.

Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.

But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.

"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.

"This is the first quantitative and biologically plausible explanation that has been developed."

One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.

"That's an area of great interest for us and we certainly continue to pursue that," he said.

D.Wang--ThChM